Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Btbd8 | Mouse | (+)-catechin | multiple interactions | ISO | BTBD8 (Homo sapiens) | 6480464 | [Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of BTBD8 mRNA | CTD | PMID:24763279 | Btbd8 | Mouse | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | BTBD8 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of BTBD8 mRNA | CTD | PMID:22079256 | Btbd8 | Mouse | 2-palmitoylglycerol | increases expression | ISO | BTBD8 (Homo sapiens) | 6480464 | 2-palmitoylglycerol results in increased expression of BTBD8 mRNA | CTD | PMID:37199045 | Btbd8 | Mouse | acrolein | multiple interactions | ISO | BTBD8 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of BTBD8 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of BTBD8 mRNA | CTD | PMID:32699268 | Btbd8 | Mouse | alpha-pinene | multiple interactions | ISO | BTBD8 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of BTBD8 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of BTBD8 mRNA | CTD | PMID:32699268 | Btbd8 | Mouse | aristolochic acid A | decreases expression | ISO | BTBD8 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of BTBD8 mRNA | CTD | PMID:33212167 | Btbd8 | Mouse | bis(2-ethylhexyl) phthalate | decreases expression | ISO | BTBD8 (Homo sapiens) | 6480464 | Diethylhexyl Phthalate results in decreased expression of BTBD8 mRNA | CTD | PMID:31163220 | Btbd8 | Mouse | bisphenol A | increases expression | ISO | BTBD8 (Homo sapiens) | 6480464 | bisphenol A results in increased expression of BTBD8 mRNA | CTD | PMID:29275510 | Btbd8 | Mouse | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of BTBD8 mRNA | CTD | PMID:33221593 | Btbd8 | Mouse | Brodifacoum | decreases expression | ISO | Btbd8 (Rattus norvegicus) | 6480464 | bromfenacoum results in decreased expression of BTBD8 protein | CTD | PMID:28903499 | Btbd8 | Mouse | butanal | decreases expression | ISO | BTBD8 (Homo sapiens) | 6480464 | butyraldehyde results in decreased expression of BTBD8 mRNA | CTD | PMID:26079696 | Btbd8 | Mouse | chlorpyrifos | decreases expression | EXP | | 6480464 | Chlorpyrifos results in decreased expression of BTBD8 mRNA | CTD | PMID:37019170 | Btbd8 | Mouse | cisplatin | multiple interactions | ISO | BTBD8 (Homo sapiens) | 6480464 | [Cisplatin co-treated with jinfukang] results in increased expression of BTBD8 mRNA | CTD | PMID:27392435 | Btbd8 | Mouse | Dibutyl phosphate | affects expression | ISO | BTBD8 (Homo sapiens) | 6480464 | di-n-butylphosphoric acid affects the expression of BTBD8 mRNA | CTD | PMID:37042841 | Btbd8 | Mouse | dichloroacetic acid | increases expression | EXP | | 6480464 | Dichloroacetic Acid results in increased expression of BTBD8 mRNA | CTD | PMID:28962523 | Btbd8 | Mouse | dorsomorphin | multiple interactions | ISO | BTBD8 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | Btbd8 | Mouse | folic acid | decreases expression | EXP | | 6480464 | Folic Acid results in decreased expression of BTBD8 mRNA | CTD | PMID:25629700 | Btbd8 | Mouse | genistein | increases expression | ISO | BTBD8 (Homo sapiens) | 6480464 | Genistein results in increased expression of BTBD8 protein | CTD | PMID:20884965 | Btbd8 | Mouse | genistein | decreases expression | EXP | | 6480464 | Genistein results in decreased expression of BTBD8 mRNA | CTD | PMID:32186404 | Btbd8 | Mouse | genistein | multiple interactions | ISO | BTBD8 (Homo sapiens) | 6480464 | ESR2 promotes the reaction [Genistein results in increased expression of BTBD8 protein] | CTD | PMID:20884965 | Btbd8 | Mouse | glyphosate | increases methylation | ISO | Btbd8 (Rattus norvegicus) | 6480464 | Glyphosate results in increased methylation of BTBD8 gene | CTD | PMID:31011160 | Btbd8 | Mouse | lead(0) | affects splicing | ISO | BTBD8 (Homo sapiens) | 6480464 | Lead affects the splicing of BTBD8 mRNA | CTD | PMID:28903495 | Btbd8 | Mouse | lead(0) | affects expression | ISO | BTBD8 (Homo sapiens) | 6480464 | Lead affects the expression of BTBD8 mRNA | CTD | PMID:28903495 | Btbd8 | Mouse | leflunomide | increases expression | ISO | BTBD8 (Homo sapiens) | 6480464 | leflunomide results in increased expression of BTBD8 mRNA | CTD | PMID:28988120 | Btbd8 | Mouse | Licochalcone B | decreases expression | ISO | BTBD8 (Homo sapiens) | 6480464 | licochalcone B results in decreased expression of BTBD8 mRNA | CTD | PMID:33647349 | Btbd8 | Mouse | melphalan | decreases expression | ISO | BTBD8 (Homo sapiens) | 6480464 | Melphalan results in decreased expression of BTBD8 mRNA | CTD | PMID:22363485 | Btbd8 | Mouse | methylmercury chloride | decreases expression | ISO | BTBD8 (Homo sapiens) | 6480464 | methylmercuric chloride results in decreased expression of BTBD8 mRNA | CTD | PMID:23179753 and PMID:28001369 | Btbd8 | Mouse | nickel atom | decreases expression | ISO | BTBD8 (Homo sapiens) | 6480464 | Nickel results in decreased expression of BTBD8 mRNA | CTD | PMID:25583101 | Btbd8 | Mouse | ozone | multiple interactions | ISO | BTBD8 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of BTBD8 mRNA more ... | CTD | PMID:32699268 | Btbd8 | Mouse | paracetamol | increases expression | ISO | BTBD8 (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of BTBD8 mRNA | CTD | PMID:22230336 | Btbd8 | Mouse | pentanal | decreases expression | ISO | BTBD8 (Homo sapiens) | 6480464 | pentanal results in decreased expression of BTBD8 mRNA | CTD | PMID:26079696 | Btbd8 | Mouse | perfluorooctane-1-sulfonic acid | multiple interactions | EXP | | 6480464 | [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of BTBD8 mRNA | CTD | PMID:36331819 | Btbd8 | Mouse | phenylmercury acetate | multiple interactions | ISO | BTBD8 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BTBD8 mRNA | CTD | PMID:27188386 | Btbd8 | Mouse | phenylmercury acetate | decreases expression | ISO | BTBD8 (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in decreased expression of BTBD8 mRNA | CTD | PMID:26272509 | Btbd8 | Mouse | potassium chromate | decreases expression | ISO | BTBD8 (Homo sapiens) | 6480464 | potassium chromate(VI) results in decreased expression of BTBD8 mRNA | CTD | PMID:22079256 | Btbd8 | Mouse | potassium chromate | multiple interactions | ISO | BTBD8 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of BTBD8 mRNA | CTD | PMID:22079256 | Btbd8 | Mouse | SB 431542 | multiple interactions | ISO | BTBD8 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | Btbd8 | Mouse | sodium arsenite | increases expression | ISO | BTBD8 (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of BTBD8 mRNA | CTD | PMID:38568856 | Btbd8 | Mouse | sunitinib | decreases expression | ISO | BTBD8 (Homo sapiens) | 6480464 | Sunitinib results in decreased expression of BTBD8 mRNA | CTD | PMID:31533062 | Btbd8 | Mouse | thapsigargin | increases expression | ISO | Btbd8 (Rattus norvegicus) | 6480464 | Thapsigargin results in increased expression of BTBD8 protein | CTD | PMID:35544339 | Btbd8 | Mouse | titanium dioxide | increases expression | EXP | | 6480464 | titanium dioxide results in increased expression of BTBD8 mRNA | CTD | PMID:29264374 | Btbd8 | Mouse | trichostatin A | multiple interactions | ISO | BTBD8 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BTBD8 mRNA | CTD | PMID:27188386 | Btbd8 | Mouse | trichostatin A | decreases expression | ISO | BTBD8 (Homo sapiens) | 6480464 | trichostatin A results in decreased expression of BTBD8 mRNA | CTD | PMID:24935251 and PMID:26272509 | Btbd8 | Mouse | triphenyl phosphate | affects expression | ISO | BTBD8 (Homo sapiens) | 6480464 | triphenyl phosphate affects the expression of BTBD8 mRNA | CTD | PMID:37042841 | Btbd8 | Mouse | valproic acid | multiple interactions | ISO | BTBD8 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BTBD8 mRNA | CTD | PMID:27188386 | Btbd8 | Mouse | valproic acid | decreases expression | ISO | BTBD8 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of BTBD8 mRNA | CTD | PMID:23179753 more ... | |